Importantly, the depletion of DNMT3a in the B cell lineage results in the leukemic transformation of B1a cells in the CLL mouse model (65), and CD38 is a marker of human CLL B cell activation (66). This evidence concerns the gene DNMT3A and B-cell chronic lymphocytic leukemia.